ES2567161T3 - Procedimiento para el cultivo de células para la producción de sustancias - Google Patents

Procedimiento para el cultivo de células para la producción de sustancias Download PDF

Info

Publication number
ES2567161T3
ES2567161T3 ES10152393.4T ES10152393T ES2567161T3 ES 2567161 T3 ES2567161 T3 ES 2567161T3 ES 10152393 T ES10152393 T ES 10152393T ES 2567161 T3 ES2567161 T3 ES 2567161T3
Authority
ES
Spain
Prior art keywords
glucose
procedure
qglcmáx
consumption rate
limitation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES10152393.4T
Other languages
English (en)
Spanish (es)
Inventor
Ruth Essers
Jochen Gaetgens
Thomas Link
Thomas Noll
Kerstin SKOPNIK
Christian Wandrey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2567161T3 publication Critical patent/ES2567161T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES10152393.4T 2002-11-27 2003-11-07 Procedimiento para el cultivo de células para la producción de sustancias Expired - Lifetime ES2567161T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255508A DE10255508A1 (de) 2002-11-27 2002-11-27 Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
DE10255508 2002-11-27

Publications (1)

Publication Number Publication Date
ES2567161T3 true ES2567161T3 (es) 2016-04-20

Family

ID=32318751

Family Applications (3)

Application Number Title Priority Date Filing Date
ES10152393.4T Expired - Lifetime ES2567161T3 (es) 2002-11-27 2003-11-07 Procedimiento para el cultivo de células para la producción de sustancias
ES10176622T Expired - Lifetime ES2749217T3 (es) 2002-11-27 2003-11-07 Procedimiento para cultivar células para la producción de sustancias
ES03767406T Expired - Lifetime ES2340377T3 (es) 2002-11-27 2003-11-07 Procedimiento para el cultivo de celulas para la produccion de substancias.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES10176622T Expired - Lifetime ES2749217T3 (es) 2002-11-27 2003-11-07 Procedimiento para cultivar células para la producción de sustancias
ES03767406T Expired - Lifetime ES2340377T3 (es) 2002-11-27 2003-11-07 Procedimiento para el cultivo de celulas para la produccion de substancias.

Country Status (12)

Country Link
US (2) US20060127975A1 (enExample)
EP (3) EP2275530B1 (enExample)
JP (2) JP4469283B2 (enExample)
AT (1) ATE462013T1 (enExample)
CY (2) CY1110267T1 (enExample)
DE (2) DE10255508A1 (enExample)
DK (2) DK1585810T3 (enExample)
ES (3) ES2567161T3 (enExample)
HU (1) HUE028862T2 (enExample)
PT (1) PT1585810E (enExample)
SI (3) SI1585810T1 (enExample)
WO (1) WO2004048556A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736282B2 (en) 1997-03-21 2001-07-26 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for sensitized T cell- mediated diseases comprising IL-6 antagonist as an active ingredient
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
SI1623019T1 (sl) * 2003-05-15 2010-10-29 Wyeth Llc Omejeno glukozno dovajanje za živalsko celično kulturo
PE20091174A1 (es) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
DE102008002210A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von Erythropoietin
AU2015203309B2 (en) * 2009-10-26 2016-05-05 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
AU2016210748B2 (en) * 2009-10-26 2018-03-01 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
HUE033758T2 (en) * 2009-10-26 2017-12-28 Hoffmann La Roche A method for producing glycosylated immunoglobulin
TWI563090B (en) * 2009-12-22 2016-12-21 Dsm Ip Assets Bv The preparation of caprolactam from 6-amino caproic acid obtained in a fermentation process
EP4029881A1 (en) 2010-11-08 2022-07-20 F. Hoffmann-La Roche AG Subcutaneously administered anti-il-6 receptor antibody
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
EP3119876B1 (en) 2014-03-19 2024-12-18 Pfizer Inc. Method of cell culture
US10738334B2 (en) 2015-09-23 2020-08-11 Pfizer Inc. Cells having reduced BCAT1
WO2020115655A1 (en) 2018-12-06 2020-06-11 Pfizer Inc. Cells with reduced inhibitor production and methods of use thereof
WO2025088516A1 (en) 2023-10-26 2025-05-01 Pfizer Inc. Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product including multi-specific antibodies thus obtained

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657863A (en) * 1982-07-02 1987-04-14 Celanese Corporation Stabilization of a mutant microorganism population
JPH066054B2 (ja) * 1987-10-15 1994-01-26 帝人株式会社 動物細胞の培養方法
ATE125157T1 (de) * 1990-04-03 1995-08-15 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
EP0592692B1 (en) * 1992-05-01 1997-07-02 Teijin Limited Fed batch process for protein secreting cells
GB9506249D0 (en) * 1995-03-27 1995-05-17 Karobio Ab Media for insect cell cultures
WO1998041611A1 (en) 1997-03-20 1998-09-24 Regents Of The University Of Minnesota Process for the continuous culture of cells
US6338964B1 (en) * 1999-05-07 2002-01-15 Bayer Corporation Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration

Also Published As

Publication number Publication date
EP2275530A2 (de) 2011-01-19
JP2010110331A (ja) 2010-05-20
CY1110267T1 (el) 2015-01-14
US20140329277A1 (en) 2014-11-06
SI1585810T1 (sl) 2010-06-30
EP2226381B1 (de) 2016-03-09
ES2340377T3 (es) 2010-06-02
PT1585810E (pt) 2010-05-05
EP2275530A3 (de) 2012-05-23
DE10255508A1 (de) 2004-06-17
EP1585810B1 (de) 2010-03-24
DK1585810T3 (da) 2010-06-07
SI2275530T1 (sl) 2019-11-29
JP5221573B2 (ja) 2013-06-26
JP2006507821A (ja) 2006-03-09
JP4469283B2 (ja) 2010-05-26
ATE462013T1 (de) 2010-04-15
SI2226381T1 (sl) 2016-05-31
DK2226381T3 (en) 2016-04-11
WO2004048556A1 (de) 2004-06-10
EP2275530B1 (de) 2019-08-07
DE50312554D1 (de) 2010-05-06
HUE028862T2 (en) 2017-01-30
EP2226381A1 (de) 2010-09-08
EP1585810A1 (de) 2005-10-19
CY1117558T1 (el) 2017-04-26
US20060127975A1 (en) 2006-06-15
ES2749217T3 (es) 2020-03-19

Similar Documents

Publication Publication Date Title
ES2567161T3 (es) Procedimiento para el cultivo de células para la producción de sustancias
CA2439387A1 (en) Artificial dermis and production method therefor
CN101578957A (zh) 超生波快速繁苗系统
Chan What Is Physiology?
CN113073121A (zh) 一种含高聚合度多聚磷酸盐的纳米碳材料及高聚合度多聚磷酸盐的制备方法
WO2018088559A1 (ja) 成長促進水溶液とその製造装置並びに農作物および魚類の生産方法
CN106577278B (zh) 促进牛大力毛状根多糖积累的方法
CN110615434A (zh) 一种利用骨灰制备人工钻石的方法及其产品
CN112655554B (zh) 一种基于led光质加速诱导苹果愈伤组织及生长的方法
CN102239783B (zh) 一种抑制真姬菇生育后期菌盖结瘤的方法
CN1343523A (zh) 微孔异体(种)无细胞真皮替代物
CN110938138B (zh) 一种同时提取藻蓝蛋白和甘油葡萄糖苷的方法
CN116083340A (zh) 一种抑制黑化反应、低内毒素的家蚕血淋巴液的制备方法
Lian et al. Mass production of lilium bulblets in bioreactors
CN106416756A (zh) 一种蛹虫草光照间断培育工艺
CN201319786Y (zh) 闭锁式超声波生物育苗装置
CN104293733B (zh) 卵巢组织冻融后早期体外培养液及培养方法
Niu The Essence of Nature Can be the Simplest (6)–Lifespan: Determined by Extracellular Fenton Chemistry
JPH08154663A (ja) 生体組織維持容器
Holmes et al. Comparison of humidified versus non-humidified incubation with sequential culture media in a time-lapse incubator using sibling oocyte splits
TW200827440A (en) An attacking separation method for embryonic stem cell membrane
JP6735460B2 (ja) 分化細胞の生産方法
KR100371274B1 (ko) 모발 이식용 키트
CN105586374A (zh) 一种基于代谢参数还原糖补糖生产多拉菌素工艺
KR20020005331A (ko) 모낭 세포의 배양 방법 및 모발 이식용 키트